Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 批发和零售业
Company Introduction 九州通医药集团股份有限公司是一家以药品、医疗器械等产品的批发、零售连锁及药品生产和研发以及有关增值服务为核心业务的中外合资股份公司.公司现时经营的药品、医疗器械品种品规达14,000 多个,拥有上游供货商4,200 多家,及下游客户69,800多家,取得了国内230 多种药品的全国或区域总经销或总代理资格,并初步形成了覆盖全国大部分县级行政区域的物流配送网络.公司是全国最大的三家医药商业流通企业之一,是医药商业领域仅有的具有全国性网络的两家企业之一.据中国医药商业协会统计数据显示,2003年至2008年,公司已连续6年位列中国医药商业企业第3位、中国民营医药商业企业第1位。
Main Business 数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、新零售与万店加盟业务（C端）、医疗健康（C端）与技术增值服务、数字物流技术与供应链解决方案六大方面。
Legal Representative 刘长云
Top Executives
董事长：刘长云
名誉董事长：刘宝林
副董事长：刘登攀,龚翼华,刘兆年
董事：贺威,王琦,吴雪松,龚翼华
独立董事：曾湘泉,汤谷良,陆银娣,艾华
Top 5 Shareholder
Shareholder name Nature Holding Date
上海弘康实业投资有限公司流通A股21.58%31/03/2024
狮龙国际集团(香港)有限公司流通A股11.41%31/03/2024
中山广银投资有限公司流通A股6.65%31/03/2024
北京点金投资有限公司流通A股5.48%31/03/2024
楚昌投资集团有限公司流通A股5.37%31/03/2024
Company Secretary 刘志峰
Solicitors 北京海润天睿律师事务所
Auditors 中审众环会计师事务所（特殊普通合伙）
Tel No 027-84683017
Fax No 027-84451256
Website www.jztey.com
Email jztdmc@jztey.com
Company Address
Register: 湖北省武汉市汉阳区龙兴西街5号
Office: 湖北省武汉市汉阳区龙兴西街5号
Listing Date 02/11/2010
Shares Capital
Shares Capital: 3,908,891,654
Total A Share: 3,908,891,654
Listed A Share: 3,908,891,654
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.550
DPS(RMB)* ¥ 0.250
NBV Per Share(RMB)* ¥ 6.136
Market Capitalization(RMB) 28.926B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.